Laman UtamaEMCURE • NSE
add
Emcure Pharmaceuticals Ltd
Tutup sebelumnya
₹1,021.90
Julat hari
₹1,006.00 - ₹1,036.00
Julat tahun
₹889.00 - ₹1,580.00
Permodalan pasaran
194.11B INR
Bilangan Purata
138.44K
Nisbah P/E
32.11
Hasil dividen
-
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 19.63B | 17.69% |
Perbelanjaan pengendalian | 9.15B | 9.37% |
Pendapatan bersih | 1.54B | 35.49% |
Margin untung bersih | 7.83 | 15.15% |
Pendapatan bagi setiap syer | 8.12 | — |
EBITDA | 3.31B | 24.75% |
Kadar cukai berkesan | 32.11% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.32B | — |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | 43.03B | — |
Syer tertunggak | 189.31J | — |
Harga kepada buku | 4.67 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 12.06% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.54B | 35.49% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Diasaskan
16 Apr 1981
Tapak web
Pekerja
11,146
